[Lupus erythematosus syndrome in the course of procainamide treatment].
D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000276:immunology; D009203:Myocardial Infarction / Q000188:drug therapy; D011342:Procainamide / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D000637:Transaminases / Q000097:blood
D000906:Antibodies; D000974:Antibodies, Antinuclear; D000637:Transaminases; D011342:Procainamide
Zespół liszaja rumieniowatego w przebiegu leczenia pronestylem.